Corticosteroids for Guillain‐Barré syndrome
RAC Hughes, R Brassington, AA Gunn… - Cochrane Database …, 2016 - cochranelibrary.com
RAC Hughes, R Brassington, AA Gunn, PA van Doorn
Cochrane Database of Systematic Reviews, 2016•cochranelibrary.comBackground Guillain‐Barré syndrome (GBS) is an acute paralysing disease caused by
inflammation of the peripheral nerves, which corticosteroids would be expected to benefit.
Objectives To examine the ability of corticosteroids to hasten recovery and reduce the long‐
term morbidity from GBS.
inflammation of the peripheral nerves, which corticosteroids would be expected to benefit.
Objectives To examine the ability of corticosteroids to hasten recovery and reduce the long‐
term morbidity from GBS.
Background
Guillain‐Barré syndrome (GBS) is an acute paralysing disease caused by inflammation of the peripheral nerves, which corticosteroids would be expected to benefit.
Objectives
To examine the ability of corticosteroids to hasten recovery and reduce the long‐term morbidity from GBS.
cochranelibrary.com